Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bossi

Showing results (21-30 of 383) with videos related to

Pageof 39
Sort By:
Current Opinion in Oncology|March 23, 2021
Sinonasal cancers treatments: state of the artMarco Ferrari, Ester Orlandi, Paolo Bossi
The New England Journal of Medicine|March 15, 2008
TP53 mutations in head and neck cancerFederica Perrone, Paolo Bossi, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Dermatology Practical & Conceptual|November 22, 2023
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New ChallengesLuigi Lorini, Andrea Alberti, Paolo Bossi
British Journal of Cancer|August 12, 2015
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'Paolo Bossi, Ester Orlandi, Lisa Licitra
JAMA|November 28, 2023
Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the BetterPaolo Bossi, Cristina Gurizzan, Anthony Chan
Current Opinion in Otolaryngology & Head and Neck Surgery|January 4, 2021
Oral potentially malignant disorders: new insights for future treatmentCrisitna Gurizzan, Luigi Lorini, Paolo Bossi
Current Treatment Options in Oncology|October 29, 2017
The Case Volume Issue in Head and Neck OncologySalvatore Alfieri, Ester Orlandi, Paolo Bossi
Current Opinion in Otolaryngology & Head and Neck Surgery|January 30, 2019
Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practicePetr Szturz, Paolo Bossi, Jan B Vermorken
Expert Review of Anticancer Therapy|November 21, 2007
Biological agents in head and neck cancerPaolo Bossi, Laura D Locati, Lisa Licitra
Pageof 39

Showing results (21-30 of 383) with videos related to

Sort By:
Pageof 39
Current Opinion in Oncology|March 23, 2021
Sinonasal cancers treatments: state of the artMarco Ferrari, Ester Orlandi, Paolo Bossi
The New England Journal of Medicine|March 15, 2008
TP53 mutations in head and neck cancerFederica Perrone, Paolo Bossi, Lisa Licitra
Expert Opinion on Emerging Drugs|October 8, 2013
Emerging tyrosine kinase inhibitors for head and neck cancerPaolo Bossi, Laura Locati, Lisa Licitra
Dermatology Practical & Conceptual|November 22, 2023
Advanced Cutaneous Squamous Cell Carcinoma Management in Immunotherapy Era: Achievements and New ChallengesLuigi Lorini, Andrea Alberti, Paolo Bossi
British Journal of Cancer|August 12, 2015
Comment on 'Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'Paolo Bossi, Ester Orlandi, Lisa Licitra
JAMA|November 28, 2023
Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the BetterPaolo Bossi, Cristina Gurizzan, Anthony Chan
Current Opinion in Otolaryngology & Head and Neck Surgery|January 4, 2021
Oral potentially malignant disorders: new insights for future treatmentCrisitna Gurizzan, Luigi Lorini, Paolo Bossi
Current Treatment Options in Oncology|October 29, 2017
The Case Volume Issue in Head and Neck OncologySalvatore Alfieri, Ester Orlandi, Paolo Bossi
Current Opinion in Otolaryngology & Head and Neck Surgery|January 30, 2019
Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practicePetr Szturz, Paolo Bossi, Jan B Vermorken
Expert Review of Anticancer Therapy|November 21, 2007
Biological agents in head and neck cancerPaolo Bossi, Laura D Locati, Lisa Licitra
Pageof 39